T
53
3
URBN
43
3
COP
54
-6
ADSK
63
5
SYK
39
2
K
51
-2
USB
48
-5
NTAP
67
2
PPG
56
-2
GM
65
4
CMG
63
3
DVN
39
-4
BEN
38
-2
ADBE
44
3
HD
58
3
EOG
59
-5
DAL
59
2
GOOG
61
2
CHRW
47
3
CCL
67
6
T
53
3
URBN
43
3
COP
54
-6
ADSK
63
5
SYK
39
2
K
51
-2
USB
48
-5
NTAP
67
2
PPG
56
-2
GM
65
4
CMG
63
3
DVN
39
-4
BEN
38
-2
ADBE
44
3
HD
58
3
EOG
59
-5
DAL
59
2
GOOG
61
2
CHRW
47
3
CCL
67
6
Financhill
Back

Longboard Pharmaceuticals Stock Predictions

Why Over 21,997 Investors Are Flocking to This Opportunity

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51

LBPH
Longboard Pharmaceuticals

Last Price:
33.59
Seasonality Move:
-17.08%

7 Day Trial

ALL ACCESS PASS

$ 7

The Tech Disruption Wall Street Isn't Talking About...Yet

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Longboard Pharmaceuticals Stock Forecast

  • Over the next 52 weeks, Longboard Pharmaceuticals has on average historically risen by 163.5% based on the past 3 years of stock performance.
  • Longboard Pharmaceuticals has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Longboard Pharmaceuticals Stock Undervalued?
    The current Longboard Pharmaceuticals [LBPH] share price is $33.63. The Score for LBPH is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • LBPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Longboard Pharmaceuticals Stock Go Up Next Year?

  • Over the next 52 weeks, Longboard Pharmaceuticals has on average historically risen by 163.5% based on the past 3 years of stock performance.

Longboard Pharmaceuticals Stock Rating

Buy
51
Longboard Pharmaceuticals (LBPH) is a Buy

Is Longboard Pharmaceuticals overpriced?

  • Longboard Pharmaceuticals has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Longboard Pharmaceuticals Stock Price History

Is LBPH stock going to rise?

  • The current trend is moderately bearish and LBPH is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
longboardpharma.com

52-Week Data

52-Week High:
43.15
52-Week Low:
3.60

Prediction Charts

Market Cap:
1.31B
Price in USD:
33.63
Volume:
547.61K
Beta:
1.24

Technical Analysis

SMA50:
34.19
SMA100:
30.05
SMA200:
25.13
52-Wk Change:
534.53%

Stock Predictions

  • Is Longboard Pharmaceuticals stock public?
    Yes, Longboard Pharmaceuticals is a publicly traded company.
  • What is the Longboard Pharmaceuticals stock quote today?
    The Longboard Pharmaceuticals stock price is 33.63 USD today.
  • How to buy Longboard Pharmaceuticals stock online?
    You can buy Longboard Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Sep-19 29.80 33.44 34.31 28.59
Sep-20 33.61 33.89 35.10 33.44
Sep-23 33.83 32.91 35.13 32.45
Sep-24 32.91 32.67 33.44 31.86
Sep-25 32.54 31.26 34.18 30.73
Sep-26 31.43 31.20 32.51 30.74
Sep-27 31.37 32.00 32.21 30.70
Sep-30 32.08 33.37 33.70 31.38
Oct-1 33.29 37.15 40.41 33.08
Oct-2 38.87 36.42 43.15 36.24
Oct-3 36.12 36.05 37.42 34.78
Oct-4 35.50 36.22 37.58 35.21
Oct-7 36.16 33.35 36.93 33.10
Oct-8 33.33 33.63 35.50 33.08

Longboard Pharmaceuticals Earnings

Longboard Pharmaceuticals Earnings Report: Per Share Longboard Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Longboard Pharmaceuticals Forecast Revenue Growth

Longboard Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Longboard Pharmaceuticals and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and a decrease next year of $0.53 per share.

* Longboard Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.